OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.657
-0.253 (-8.69%)
At close: Oct 29, 2024, 4:00 PM
2.590
-0.067 (-2.52%)
After-hours: Oct 29, 2024, 7:53 PM EDT

OS Therapies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Cost of Revenue
0.010.0101.164.25
Gross Profit
-0.01-0.01-0-1.16-4.25
Selling, General & Admin
0.951.121.151.50.8
Research & Development
2.233.223.292.170.6
Operating Expenses
3.184.344.453.681.4
Operating Income
-3.19-4.34-4.45-4.84-5.65
Interest Expense
-3.27-3.45-1.81-2.58-0.46
Interest & Investment Income
00--0.06
Other Non Operating Income (Expenses)
----0.02
Pretax Income
-6.46-7.79-6.25-7.42-6.03
Net Income
-6.46-7.79-6.25-7.42-6.03
Preferred Dividends & Other Adjustments
0.090.130.130.09-
Net Income to Common
-6.55-7.92-6.38-7.51-6.03
Shares Outstanding (Basic)
111110108
Shares Outstanding (Diluted)
111110108
Shares Change (YoY)
8.92%7.01%-18.50%-
EPS (Basic)
-0.60-0.74-0.64-0.75-0.72
EPS (Diluted)
-0.60-0.74-0.64-0.75-0.72
Free Cash Flow
-3.27-3.01-3.79-4.41-2.42
Free Cash Flow Per Share
-0.30-0.28-0.38-0.44-0.29
EBITDA
-3.18-4.34-4.45-4.84-5.65
D&A For EBITDA
00000
EBIT
-3.19-4.34-4.45-4.84-5.65
Source: S&P Capital IQ. Standard template. Financial Sources.